While generally safe, its important to consult with a healthcare provider to ensure they are appropriate for you, especially if you have underlying health conditions
In 2022 the FDA issued guidance explicitly stating that BPC 157 is not an acceptable candidate for use in compounded drug preparations under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
Mar 3 2020;3(3):CD001838
More clinical evidence is needed before BPC-157 can be formally recognized as a treatment for specific medical conditions
Because Crohns causes inflammation of the intestinal tract, it not only interferes with B12 absorption but can cause more severe symptoms like arthritis, skin problems, fevers, rectal bleeding, and abdominal pain
inconsistent human metabolic results